What you get
- The specific aims page decides most applications; it is where the engagement starts.
- Written with a PhD scientist who has worked on both sides of NIH review.
- Covers R01, R21, R03, and NIH SBIR and STTR, plus resubmissions with an introduction to review.
- Flat fee quoted up front, never a percentage of the award.
NIH grant writing services support applications where the science is yours and the framing decides the outcome. Our research work is led by a PhD scientist who has written, reviewed, and revised NIH applications, and the engagement is built around the part of the application that carries the most weight: the specific aims page.
Where NIH applications are actually won and lost
Study section members arrive with a large stack and limited time. Two or three assigned reviewers read closely; the rest of the panel forms an impression largely from the aims page and the discussion.
That reality drives everything about how these applications should be built.
The specific aims page is the application. One page determines whether the reviewer reads the research strategy generously or skeptically. It has to establish the problem, the gap, a falsifiable hypothesis, aims that stand independently, and the impact, without hedging. Our annotated specific aims examples show what that looks like executed, and how to write specific aims covers the underlying arc.
Dependent aims are a scored weakness. If Aim 1 failing invalidates Aims 2 and 3, a reviewer will say so. Restructuring aims for independence is one of the most common and most valuable changes we make.
Rigor and feasibility must be addressed explicitly. Reviewers are instructed to assess them, and applications that assume competence rather than demonstrating it lose points that were freely available.
The unwritten objection sinks applications. Every proposal has an obvious criticism the applicant has stopped seeing. Surfacing and pre-empting it is much of what an outside specialist contributes.
What we cover
Specific aims development. Usually the first two to three weeks. Iterated, because the aims page is where structural problems in the whole project surface.
Research strategy. Significance, innovation, and approach, drafted or substantially edited. Your science, structured so a non-specialist panel member can follow the argument and an expert reviewer finds their objections already answered.
Biosketches. Tailored personal statements for each senior and key person, and contributions to science written as narratives rather than publication lists. Our NIH biosketch example shows the standard.
Budget and justification. A compliant budget with correct level of effort in person-months, salary cap handling, and an indirect cost calculation on the right base.
Forms and assembly. The full package, including the SF-424 family where applicable, and the assembly checks that catch compliance failures before submission.
Internal review. A read against the criteria a study section applies, before your institution sees it. This is the same discipline as our standalone proposal review.
Mechanisms we work on
- R01: the standard research project grant. The most demanding and the most common.
- R21: exploratory and developmental. Shorter, and rewards a sharply bounded question rather than a compressed R01.
- R03: small grant, limited scope.
- NIH SBIR and STTR: Phase I and Phase II, where the commercialization argument matters as much as the science. See SBIR and STTR grant writing.
- Resubmissions: including the one-page introduction to review.
Resubmissions
A resubmission is frequently the best return available, because a scored application has already told you what to fix.
The work turns on the introduction to the resubmission. One page, responding to the summary statement, and the most common failure is tonal: applicants defend rather than revise. Reviewers who see their critiques dismissed score accordingly, and often the same reviewers see it again.
A strong introduction acknowledges each substantive critique accurately, describes what changed, and points to where. Where you disagree with a critique, it engages with the reasoning rather than restating the original position. That is a difficult document to write about your own work, which is precisely why an outside reader helps.
Timeline
Twelve weeks before the deadline for a new R01; eight for an R21 or SBIR Phase I.
That is not padding. Two to three weeks belong to the aims page, and compressing that is a false economy given how much rests on it. Institutional sign-off, subaward documentation from collaborating institutions, and letters of support all take longer than expected. Applications started at four weeks get rushed in the sections reviewers read most carefully.
Why flat-fee, never commission
We quote a flat fee before any work starts, and never a percentage of the award. Contingency pricing violates the GPA code of ethics, and proposal preparation costs are generally unallowable under federal cost principles in any case.
There is a second reason it matters here. A writer paid on outcome has an incentive to push an application that is not ready. We would rather tell you the aims page needs another cycle and the next deadline is the right one, advice that is worth having and that commission pricing makes impossible to give honestly.
What we do not promise
We cannot promise a fundable score. Anyone who does is either misleading you or does not understand NIH review, where paylines, panel composition, and the applicant pool that cycle are outside anyone's control.
What we deliver is an application whose aims are structured to survive scrutiny, whose weaknesses have been surfaced and addressed rather than discovered by reviewers, and which is compliant on submission.
How to get started
Send us your aims draft or a summary of the project and the mechanism you are targeting, and a specialist will return a written, flat-fee quote, usually within one business day. Nothing is due until you approve the scope and price.
For background, see our overview of NIH grants. For NSF applications, see NSF grant writing.
